Association of interleukin-10 gene variation with breast cancer prognosis

作者: Armin Gerger , Wilfried Renner , Tanja Langsenlehner , Günter Hofmann , Gudrun Knechtel

DOI: 10.1007/S10549-009-0417-Y

关键词:

摘要: Genetic polymorphisms are responsible for inter-individual variation and diversity have been recently considered as the main genetic elements involved in development progression of cancer. We examined associations between common germline variants 7 genes folate metabolism, cell proliferation apoptosis, prostaglandin synthesis, detoxification compounds inflammation, disease-free survival among women diagnosed with invasive breast DNA from up to 432 was genotyped 8 polymorphisms. The genotypes each polymorphism were tested association using univariate multivariate Cox regression analysis. model adjusted known cancer prognostic factors. rare allele IL-10 592C>A significantly associated reduced (P = 0.018, risk ratio recurrence (RR) 1.45, 95% confidence interval (CI) 1.06-1.98), which not attenuated after adjusting age at diagnosis, tumor size, lymph node status, clinical stage, histological grade, estrogen receptor progesterone treatment modalities 0.019, RR 1.48, CI 1.066-2.044). No found MTHFR 677C>T, TGFB1 29T>C, FASLG 844C>T, FAS 1377G>A, 670A>G, PTGS2 8473T>C SULT1A1 638G>A survival. Our data suggest that may be a potential marker

参考文章(26)
SP Balasubramanian, IAF Azmy, SE Higham, AG Wilson, SS Cross, A Cox, NJ Brown, MW Reed, Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review BMC Cancer. ,vol. 6, pp. 188- 188 ,(2006) , 10.1186/1471-2407-6-188
S.M. Hsieh, N.A. Lintell, K.W. Hunter, Germline Polymorphisms Are Potential Metastasis Risk and Prognosis Markers in Breast Cancer Breast Disease. ,vol. 26, pp. 157- 162 ,(2007) , 10.3233/BD-2007-26114
Kent Hunter, Host genetics influence tumour metastasis Nature Reviews Cancer. ,vol. 6, pp. 141- 146 ,(2006) , 10.1038/NRC1803
Bruce Rannala, Finding genes influencing susceptibility to complex diseases in the post-genome era. American Journal of Pharmacogenomics. ,vol. 1, pp. 203- 221 ,(2001) , 10.2165/00129785-200101030-00005
W. Martin Howell, Matthew J. Rose-Zerilli, Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Familial Cancer. ,vol. 5, pp. 143- 149 ,(2006) , 10.1007/S10689-005-0072-3
Britta Weigelt, Johannes L. Peterse, Laura J. van't Veer, Breast cancer metastasis: markers and models Nature Reviews Cancer. ,vol. 5, pp. 591- 602 ,(2005) , 10.1038/NRC1670
D. M. Turner, D. M. Williams, D. Sankaran, M. Lazarus, P. J. Sinnott, I. V. Hutchinson, An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics. ,vol. 24, pp. 1- 8 ,(1997) , 10.1111/J.1365-2370.1997.TB00001.X
Ming-Tseh Lin, Barry Storer, Paul J. Martin, Li-Hui Tseng, Ted Gooley, Pei-Jer Chen, John A. Hansen, Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation The New England Journal of Medicine. ,vol. 349, pp. 2201- 2210 ,(2003) , 10.1056/NEJMOA022060
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 74- 108 ,(2005) , 10.3322/CANJCLIN.55.2.74